Relating to: regulating hemp-derived cannabinoid products.

SB 682 regulates hemp-derived cannabinoid products containing specific cannabinoids like delta-8, delta-9, or delta-10 THC (excluding synthetic versions), directly affecting manufacturers, sellers, and consumers of these products. It requires sellers to verify customers are over 21, mandates lab testing for each batch to confirm cannabinoid content (within 10% tolerance), ensure THC levels stay below 0.3% (or federal max 1%), and confirm absence of harmful contaminants like pesticides. Products must display clear labels with manufacturer details, batch numbers, serving sizes, and a certificate of lab analysis. The bill explicitly excludes FDA-approved prescription drugs, certain cannabidiol (CBD) products governed by existing laws, and external hemp products not intended for absorption.